Phase II Trial of N-(phosphonacetyl)-l-aspartate (PALA), 5-Fluorouracil and Recombinant Interferon- -2b in Patients with Advanced Gastric Carcinoma

By Wadler S.   Gleissner B.   Hilgenfeld R.U.   Thiel E.   Haynes H.   Kaleya R.   Rozenblit A.   Kreuser E.-D.  

European Journal of Cancer, Vol. 32, Iss. 7, 1996-06 ,pp. : 1254-1256

Elsevier

Access to resources Recommend Favorite

Phase I and pharmacokinetic study of 5-fluorouracil administered by 5-day continuous infusion in patients with hepatocellular carcinoma

By Ueno Hideki   Okada Shuichi   Okusaka Takuji   Ikeda Masafumi   Kuriyama Hitoshi  

Cancer Chemotherapy and Pharmacology, Vol. 49, Iss. 2, 2002-02 ,pp. : 155-160

Springer Publishing Company

Access to resources Recommend Favorite

Phase II Trial of Doxorubicin, 5-Fluorouracil, Etoposide, and Cisplatin in Advanced or Recurrent Endometrial Carcinoma

By Pierga J.-Y.   Dieras V.   Beuzeboc P.   Dorval T.   Palangie T.   Jouve M.   Scholl S.M.   Garcia-Giralt E.   Pouillart P.  

Gynecologic Oncology, Vol. 66, Iss. 2, 1997-08 ,pp. : 246-249

Elsevier

Access to resources Recommend Favorite

A phase II study of ifosfamide, 5-fluorouracil and leucovorin in patients with recurrent nasopharyngeal carcinoma previously treated with platinum chemotherapy

By Chua D.T.T.   Kwong D.L.W.   Sham J.S.T.   Au G.K.H.   Choy D.  

European Journal of Cancer, Vol. 36, Iss. 6, 2000-04 ,pp. : 736-741

Elsevier

Access to resources Recommend Favorite

Hydroxyurea, 5-Fluorouracil Infusion, and Cisplatin Adjunct to Radiation Therapy in Cervical Carcinoma: A Phase I-II Trial of the Gynecologic Oncology Group

By Stehman F.B.   Bundy B.N.   Kucera P.R.   Deppe G.   Reddy S.   O'Connor D.M.  

Gynecologic Oncology, Vol. 66, Iss. 2, 1997-08 ,pp. : 262-267

Elsevier

Access to resources Recommend Favorite